Panel Opposes OTC Approval for Mevacor
January 17, 2005
Concerns about whether the drug could be used safely without a doctor’s guidance has led an advisory panel to argue against regulators approving the cholesterol drug, Mevacor, for sale over-the-counter.
Recent News
Tesla Accelerates the Launch of More Budget-Friendly EVs
As a result of the rapid revenue decline in the first quarter of this year, Tesla is channeling its efforts to launch more affordable EVs sooner than expected.
Congress Passed a Potential TikTok Ban, Influencers Are Worried About Their Careers
After Congress passed a potential TikTok ban, TikTokers expressed growing worry over the “devastating” impact it would have on their careers.
Merger Forces Kroger and Albertsons To Sell More Stores
Kroger and Albertsons are selling more of their stores to address concerns about their merger.
JD Sports Bids for Hibbett in $1.08 Billion Deal
JD Sports Fashion plans to buy Hibbett Inc. for around $1.08 billion. The move aims to help the UK’s largest sportswear retailer grow in the southeastern United States.